DOCSLIB.ORG

Evaluation of E-Cadherin, Β-Catenin and Vimentin Protein Expression

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Evaluation of E-Cadherin, Β-Catenin and Vimentin Protein Expression ORIGINAL RESEARCH Desirée Hao, MD1,2 Tien Phan, MD2,4 Evaluation of E-cadherin, β-catenin Amanda Jagdis, MD3 Jodi E. Siever, MSc5 and vimentin protein expression using Alexander C. Klimowicz, PhD6 Janessa J. Laskin, MD3,7 quantitative immunohistochemistry in Thomas A. Thomson, MD8 M. Sarah Rose, PhD9 nasopharyngeal carcinoma patients Stephanie K. Petrillo, MSc6 Anthony M. Magliocco, MD10 Harold Y. Lau, MD2,4 Abstract Purpose: 1 Department of Medical Oncology, Tom Baker Aberrant expression of proteins involved in epithelial-to-mesenchymal transition Cancer Centre, Calgary, Alberta, Canada have been described in various cancers. In this retrospective study, we sought to evaluate 2 Faculty of Medicine, University of Calgary, E-cadherin, β-catenin and vimentin protein expression in non-metastatic nasopharyngeal Calgary, Alberta, Canada (NPC) patients treated with curative intent, examine their relationship with each other, 3 Department of Internal Medicine, Faculty of and with clinical outcome measures. Medicine, University of British Columbia, Van- Methods: couver, British Columbia, Canada Pre-treatment formalin-fixed paraffin-embedded biopsies of 140 patients treated 4 Department of Radiation Oncology, Tom between January 2000 and December 2007 were assembled into a tissue microarray Baker Cancer Centre, Calgary, Alberta, Canada (TMA). Automated quantitative immunohistochemistry (AQUA®) was performed on 5 Senior Analyst/Biostatistics, Research & In- sequential TMA sections stained with fluorescent-labeled antibodies against E-cadherin, novation, Population, Public, and Aboriginal β-catenin and vimentin. Cox proportional hazards regression was used to estimate the ef- Health, Alberta Health Services fect of cytoplasmic vimentin, cytoplasmic E-cadherin, β-catenin nuclear/cytoplasmic ratio 6 Department of Pathology, Tom Baker Cancer expression on overall survival and disease-free survival. Centre, Calgary, Alberta, Canada Results: 7 Department of Medical Oncology, British The average age of the patients was 51.7 years (SD=12.1; range 18-85), 66% were Columbia Cancer Agency – Vancouver male, 71% had a KPS ≥ 90% at the start of treatment and 65% had stage III/IV disease. 8 Pathologist, British Columbia Cancer Agency After adjusting for performance status, WHO and stage, high E-cadherin levels over the – Vancouver and Faculty of Medicine, Univer- 75th percentile were found to produce a significantly increased risk for both a worse over- sity of British Columbia all survival (HR = 2.53, 95% CI 1.21, 5.27) and disease free survival (DFS; HR = 2.14, 9 Rho - Sigma Scientific Consultants Calgary, 95%CI 1.28, 3.59). Vimentin levels over the first quartile produced an increased risk for a Calgary, AB, Canada worse DFS (HR = 2.21, 95% CI 1.11, 4.38). No association was seen between β-catenin 10 Department of Anatomic Pathology, H. Lee and survival. Moffitt Cancer Center, Tampa, Florida, U.S.A. Conclusion: In this cohort of NPC patients, higher levels of E-cadherin and higher levels Manuscript submitted 24th April, 2014 of vimentin were associated with worse outcomes. Further work is needed to understand Manuscript accepted 9th September, 2014 the role of these epithelial mesenchymal transition proteins in NPC. Clin Invest Med 2014; 37 (5): E320-E330. Correspondence to: Desirée Hao Department of Medical Oncology Tom Baker Cancer Centre 1331 29th St NW Calgary, Alberta, Canada, T2N 4N2 E-Mail: [email protected] © 2014 CIM Clin Invest Med • Vol 37, no 5, October 2014 E320 Hao et al. E-cadherin, β-catenin and vimentin protein expression in nasopharyngeal carcinoma Epithelial mesenchymal transition (EMT) which underlies curative intent radiation ± platinum chemotherapy at British embryonic development, increasingly appears to be critical in Columbia Cancer Agency and Tom Baker Cancer Centre were the process of tumour invasion and metastases [1]. Although identified with retrievable biopsy samples, either from the pri- EMT is regulated by a complex interplay of signaling pathways, mary site or from a nodal metastasis. Tissue microarrays a hallmark of EMT is the down regulation of E-cadherin, mis- (TMAs) were constructed from duplicate 0.6 mm cores of pre- localization of β-catenin and nuclear expression of vimentin treatment formalin-fixed paraffin-embedded specimens. Fluo- [2]. E-cadherin is a transmembrane glycoprotein that is in- rescent immunohistochemistry was performed on sequential volved in mediating cell–cell adhesion between adjacent TMA sections that were co-stained with antibodies against E- epithelial cells in various tissues [3, 4]. Loss of E-cadherin has cadherin (1:200, Rabbit clone 24E10, Cell Signaling, Dan- been related to tumour aggressiveness and increased rates of vers, MA) or β-catenin (1:1000 mouse clone B-cat-1, Dako metastasis in breast, gastric, hepatocellular, bladder and pros- Cytomation, Glostrup, Denmark) and vimentin (MAB2105 tate cancer [5-10]. β-catenin is a multi-functional protein in- rat; R&D Systems, Minneapolis, MN) and pan-cytokeratin volved in the cadherin-mediated cell-cell adhesion system [11]. (AE1/AE3 or rabbit anti-cow wide spectrum screening anti- It associates with the cytoplasmic portion of E-cadherin and body, respectively; Dako Cytomation). Antibody signals was the actin cytoskeleton via α-catenin to form the adherens junc- amplified and visualized using a TSA-Plus CY5 (E-caderin and tion [12, 13]. β-catenin is also an important effector of Wnt β-catenin) or Cy3 (vimentin) Tyramide Signal Amplification signaling in the nucleus, where it regulates the expression of kit (PerkinElmer, Waltham, MA) and pan-cytokeratin was genes involved in cell growth. Unbound cytoplasmic β-catenin visualized using a goat anti-primary Alexa 555 conjugated sec- is targeted for proteosomal degradation in the absence of Wnt ondary antibody (Invitrogen, Carlsbad, CA). After staining, signaling. E-cadherin is thought to antagonize β-catenin sig- TMA slides were mounted in ProLong Gold mounting media naling by binding to it, thus keeping the level of cytoplasmic β- with diamidino-phenylindole to visualize the nucleus (Invitro- catenin low and unavailable for downstream activation of the gen). TMAs were then scanned using a HistoRx PM-2000 Wnt pathway [14, 15]. Loss of E-cadherin expression has been image analysis platform. AQUAnalysis™ software (version associated with increased localization of β-catenin to the nu- 2.3.4.1) was used to create a "mask" to isolate the epithelial/ cleus [15, 16]. Vimentin is a type III intermediate filament tumour cells within the tissue cores. E-cadherin, β-catenin or protein normally found in mesenchymal cells and is expressed vimentin pixel intensity was measured within the tumour area in epithelial cells that are migrating during embryogenesis, or- (tAQUA), cytoplasmic tumour area (cAQUA) or the nuclear ganogenesis, wound healing and tumour invasion [17]. The tumour area (nAQUA). vimentin promoter is a target of the β-catenin/T-cell factor pathway, suggesting that the functional regulation of epithelial Statistical Analysis cells is involved in tumour invasion and/or metastasis [18]. The nuclear/cytoplasm β-catenin ratio (n/cBC) was obtained Since nasopharyngeal cancers (NPC) commonly invade by dividing the nAQUA scores by the cAQUA scores [26]. For surrounding tissue or metastasize to cervical lymph nodes early vimentin and E-cadherin, cAQUA scores were used for analysis in the natural history of the disease, we sought to characterize (tumour cell cytoplasmic vimentin and tumour cell cytoplas- the protein expression of E-cadherin, β-catenin and vimentin, mic E-cadherin, respectively), and both were Z-score standard- three proteins involved in EMT, in non-metastatic NPC pa- ized between the Calgary and the Vancouver cohorts. All three tients treated with curative intent. We explored the relation- biomarkers were stratified into quartiles with the highest cate- ship among E-cadherin, β-catenin and vimentin, and their rela- gory considered to have the highest expression of the protein. tionship with clinical outcome measures. Categorical variables were expressed as a frequency and percentage; patient age was expressed as mean ± standard de- Materials and Methods viation. The correlation between the biomarkers was assessed Study Population, TMA Construction and Analysis using the Spearman rank correlation coefficient. The relation- ship between each biomarker and other variables (T-stage, N- This study was approved by the University of Calgary Conjoint stage, WHO class, and grade) was assessed using ANOVA after Health Research Ethics Board and the University of British appropriate transformations were applied to achieve an ap- Columbia, British Columbia Cancer Agency (BCCA) Re- proximately Normal distribution or the Kruskal Wallis non- search Ethics Board. Between January 2000 and December parametric test when an appropriate transformation could not 2007, 137 patients with non-metastatic NPC treated with be found. © 2014 CIM Clin Invest Med • Vol 37, no 5, October 2014 E321 Hao et al. E-cadherin, β-catenin and vimentin protein expression in nasopharyngeal carcinoma TABLE 1. Demographic and treatment characterristics for the overall sample Included Excluded Characteristic Patients Patients p (N = 137) (N=142) Age in years (Mean (SD)) 52 (12.1) 52 (13.3) 0.453 No. (%) Male gender 91 (66%) 99 (70%) 0.555 Stage I/II 48 (35%) 60 (43%) 0.819 III/IV 89 (65%) 81 (57%) KPS≥ 90% 97 (71%) 120 (84%) 0.006 WHO type 1 16 (12%) 11 (8%) 2 38 (29%) 30 (22%) 0.164 3 79 (59%) 97 (70%) RT protocol 3D conformal(66-70 Gy, 33-35 fractions) 89 (67%) 101 (75%) 0.183 IMRT(70 Gy, 33-35 fractions) 43 (33%) 34 (25%) Treatment modality RT only 80 (58%) 97 (68%) CCRT 38 (28%) 31 (22%) 0.222 Adjuvant chemotherapy 19 (14%) 14 (10%) T stage T1 49 (36%) 55 (39%) T2 39 (29%) 43 (30%) 0.709 T3 21 (15%) 16 (11%) T4 28 (20%) 28 (20%) N stage N0 44 (32%) 45 (32%) N1 36 (26%) 33 (23%) 0.864 N2/3 57 (42%) 64 (45%) 2 year locoregional control rate 113 (82%) 126 (89%) 0.136 Total Death 36 (26%) 34 (24%) 0.811 NPC-related 35/36 (97%) 32/24 (94%) Note: Denominator varies slightly due to missingg data.
Load more

Recommended publications
  • Loss of At-Catenin Alters the Hybrid Adhering Junctions in the Heart and Leads to Dilated Cardiomyopathy and Ventricular Arrhythmia Following Acute Ischemia
    1058 Research Article Loss of aT-catenin alters the hybrid adhering junctions in the heart and leads to dilated cardiomyopathy and ventricular arrhythmia following acute ischemia Jifen Li1,*, Steven Goossens2,3,`, Jolanda van Hengel2,3,`, Erhe Gao1, Lan Cheng1, Koen Tyberghein2,3, Xiying Shang1, Riet De Rycke2, Frans van Roy2,3,* and Glenn L. Radice1 1Center for Translational Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, PA, USA 2Department for Molecular Biomedical Research, Flanders Institute for Biotechnology (VIB), B-9052 Ghent, Belgium 3Department of Biomedical Molecular Biology, Ghent University, B-9052 Ghent, Belgium *Authors for correspondence ([email protected]; [email protected]) `These authors contributed equally to this work Accepted 4 October 2011 Journal of Cell Science 125, 1058–1067 ß 2012. Published by The Company of Biologists Ltd doi: 10.1242/jcs.098640 Summary It is generally accepted that the intercalated disc (ICD) required for mechano-electrical coupling in the heart consists of three distinct junctional complexes: adherens junctions, desmosomes and gap junctions. However, recent morphological and molecular data indicate a mixing of adherens junctional and desmosomal components, resulting in a ‘hybrid adhering junction’ or ‘area composita’. The a-catenin family member aT-catenin, part of the N-cadherin–catenin adhesion complex in the heart, is the only a-catenin that interacts with the desmosomal protein plakophilin-2 (PKP2). Thus, it has been postulated that aT-catenin might serve as a molecular integrator of the two adhesion complexes in the area composita. To investigate the role of aT-catenin in the heart, gene targeting technology was used to delete the Ctnna3 gene, encoding aT-catenin, in the mouse.
    [Show full text]
  • 82135357.Pdf
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Developmental Biology 319 (2008) 298–308 Contents lists available at ScienceDirect Developmental Biology journal homepage: www.elsevier.com/developmentalbiology Identification of a novel intermediate filament-linked N-cadherin/γ-catenin complex involved in the establishment of the cytoarchitecture of differentiated lens fiber cells Michelle Leonard, Yim Chan, A. Sue Menko ⁎ Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, 571 Jefferson Alumni Hall, 1020 Locust Street, Philadelphia, PA 19107, USA article info abstract Article history: Tissue morphogenesis and maintenance of complex tissue architecture requires a variety of cell–cell junctions. Received for publication 17 December 2007 Typically, cells adhere to one another through cadherin junctions, both adherens and desmosomal junctions, Revised 14 April 2008 strengthened by association with cytoskeletal networks during development. Both β-andγ-catenins are Accepted 18 April 2008 reported to link classical cadherins to the actin cytoskeleton, but only γ-catenin binds to the desmosomal Available online 8 May 2008 cadherins, which links them to intermediate filaments through its association with desmoplakin. Here we fi γ Keywords: provide the rst biochemical evidence that, in vivo, -catenin also mediates interactions between classical fi γ-catenin cadherins and the intermediate lament cytoskeleton, linked through desmoplakin. In the developing lens, Cadherin which has no desmosomes, we discovered that vimentin became linked to N-cadherin complexes in a Intermediate filament differentiation-state specific manner. This newly identified junctional complex was tissue specific but not Vimentin unique to the lens. To determine whether in this junction N-cadherin was linked to vimentin through γ- Lens development catenin or β-catenin we developed an innovative “double” immunoprecipitation technique.
    [Show full text]
  • Overexpression of Vimentin Contributes to Prostate Cancer Invasion and Metastasis Via Src Regulation
    ANTICANCER RESEARCH 28: 327-334 (2008) Overexpression of Vimentin Contributes to Prostate Cancer Invasion and Metastasis via Src Regulation JUNCHENG WEI*, GANG XU*, MINGFU WU, YONGTAO ZHANG, QIONG LI, PING LIU, TAO ZHU, ANPING SONG, LIANGPIN ZHAO, ZHIQIANG HAN, GANG CHEN, SHIXUAN WANG, LI MENG, JIANFENG ZHOU, YUNPING LU, SHIXUAN WANG and DING MA Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China Abstract. A significant proportion of prostate cancer patients Prostate carcinoma is the second leading cause of cancer- treated with curative intent develop advanced disease. At a related death in the United States and Europe (1), mainly fundamental biological level, very little is known about what due to its high potential for bone metastasis. However, the makes the disease aggressive and metastatic. Observational molecular mechanisms of prostate cancer metastasis are not pathology reports and experimental data suggest that an well understood. Among the currently available techniques, epithelial-mesenchymal transition (EMT) is involved in prostate cancer proteomics permits the analysis of thousands of cancer invasiveness. The mechanism by which vimentin modified or unmodified proteins simultaneously and has promotes prostate cancer cell invasion and metastasis was become increasingly popular for identifying biomarkers for examined. The highly metastatic human prostate epithelial cell the early detection, classification and prognosis of tumors, line PC-3M-1E8 (1E8-H) and the low metastatic line PC-3M- as well as for pinpointing molecular targets for improving 2B4 (2B4-L) were used for comparative proteomic analysis by treatment outcomes (2). two-dimensional gel electrophoresis, followed by matrix-assisted It is known that tumor progression to malignancy requires laser desorption/time of flight mass spectrometry (MALDI- a change from an epithelial phenotype to a fibroblast or TOF-MS).
    [Show full text]
  • Daam2 Couples Translocation and Clustering of Wnt Receptor Signalosomes Through Rac1 Carlo D
    © 2021. Published by The Company of Biologists Ltd | Journal of Cell Science (2021) 134, jcs251140. doi:10.1242/jcs.251140 RESEARCH ARTICLE Daam2 couples translocation and clustering of Wnt receptor signalosomes through Rac1 Carlo D. Cristobal1,QiYe2, Juyeon Jo2, Xiaoyun Ding3, Chih-Yen Wang2, Diego Cortes2, Zheng Chen4 and Hyun Kyoung Lee1,3,5,* ABSTRACT Dynamic polymerization of the Dishevelled proteins functions at Wnt signaling plays a critical role in development across species and the core of the Wnt signalosome by interacting with both the is dysregulated in a host of human diseases. A key step in signal Frizzled Wnt receptors and low-density lipoprotein receptor-related transduction is the formation of Wnt receptor signalosomes, during protein 5/6 (LRP5/6), leading to recruitment of Axin proteins β which a large number of components translocate to the membrane, from the -catenin destruction complex (MacDonald et al., 2009; cluster together and amplify downstream signaling. However, the Schwarz-Romond et al., 2007). However, the exact composition molecular processes that coordinate these events remain poorly and mechanisms of signalosome assembly at the plasma membrane defined. Here, we show that Daam2 regulates canonical Wnt remain unclear. signaling via the PIP –PIP5K axis through its association with Rac1. The hallmark of canonical Wnt signaling is the accumulation and 2 β Clustering of Daam2-mediated Wnt receptor complexes requires both translocation of -catenin into the nucleus for gene transcription, β Rac1 and PIP5K, and PIP5K promotes membrane localization of these whereas non-canonical Wnt signaling is -catenin independent and complexes in a Rac1-dependent manner. Importantly, the localization involves assembly/disassembly of the actin cytoskeleton, polarized of Daam2 complexes and Daam2-mediated canonical Wnt signaling is cell shape changes and cell migration (Niehrs, 2012; Schlessinger dependent upon actin polymerization.
    [Show full text]
  • Plakoglobin Is Required for Effective Intermediate Filament Anchorage to Desmosomes Devrim Acehan1, Christopher Petzold1, Iwona Gumper2, David D
    ORIGINAL ARTICLE Plakoglobin Is Required for Effective Intermediate Filament Anchorage to Desmosomes Devrim Acehan1, Christopher Petzold1, Iwona Gumper2, David D. Sabatini2, Eliane J. Mu¨ller3, Pamela Cowin2,4 and David L. Stokes1,2,5 Desmosomes are adhesive junctions that provide mechanical coupling between cells. Plakoglobin (PG) is a major component of the intracellular plaque that serves to connect transmembrane elements to the cytoskeleton. We have used electron tomography and immunolabeling to investigate the consequences of PG knockout on the molecular architecture of the intracellular plaque in cultured keratinocytes. Although knockout keratinocytes form substantial numbers of desmosome-like junctions and have a relatively normal intercellular distribution of desmosomal cadherins, their cytoplasmic plaques are sparse and anchoring of intermediate filaments is defective. In the knockout, b-catenin appears to substitute for PG in the clustering of cadherins, but is unable to recruit normal levels of plakophilin-1 and desmoplakin to the plaque. By comparing tomograms of wild type and knockout desmosomes, we have assigned particular densities to desmoplakin and described their interaction with intermediate filaments. Desmoplakin molecules are more extended in wild type than knockout desmosomes, as if intermediate filament connections produced tension within the plaque. On the basis of our observations, we propose a particular assembly sequence, beginning with cadherin clustering within the plasma membrane, followed by recruitment of plakophilin and desmoplakin to the plaque, and ending with anchoring of intermediate filaments, which represents the key to adhesive strength. Journal of Investigative Dermatology (2008) 128, 2665–2675; doi:10.1038/jid.2008.141; published online 22 May 2008 INTRODUCTION dense plaque that is further from the membrane and that Desmosomes are large macromolecular complexes that mediates the binding of intermediate filaments.
    [Show full text]
  • Transiently Structured Head Domains Control Intermediate Filament Assembly
    Transiently structured head domains control intermediate filament assembly Xiaoming Zhoua, Yi Lina,1, Masato Katoa,b,c, Eiichiro Morid, Glen Liszczaka, Lillian Sutherlanda, Vasiliy O. Sysoeva, Dylan T. Murraye, Robert Tyckoc, and Steven L. McKnighta,2 aDepartment of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390; bInstitute for Quantum Life Science, National Institutes for Quantum and Radiological Science and Technology, 263-8555 Chiba, Japan; cLaboratory of Chemical Physics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0520; dDepartment of Future Basic Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, Japan; and eDepartment of Chemistry, University of California, Davis, CA 95616 Contributed by Steven L. McKnight, January 2, 2021 (sent for review October 30, 2020; reviewed by Lynette Cegelski, Tatyana Polenova, and Natasha Snider) Low complexity (LC) head domains 92 and 108 residues in length are, IF head domains might facilitate filament assembly in a manner respectively, required for assembly of neurofilament light (NFL) and analogous to LC domain function by RNA-binding proteins in the desmin intermediate filaments (IFs). As studied in isolation, these IF assembly of RNA granules. head domains interconvert between states of conformational disor- IFs are defined by centrally located α-helical segments 300 to der and labile, β-strand–enriched polymers. Solid-state NMR (ss-NMR) 350 residues in length. These central, α-helical segments are spectroscopic studies of NFL and desmin head domain polymers re- flanked on either end by head and tail domains thought to be veal spectral patterns consistent with structural order.
    [Show full text]
  • Diagnostic Use of Nuclear B-Catenin Expression for the Assessment of Endometrial Stromal Tumors
    Modern Pathology (2008) 21, 756–763 & 2008 USCAP, Inc All rights reserved 0893-3952/08 $30.00 www.modernpathology.org Diagnostic use of nuclear b-catenin expression for the assessment of endometrial stromal tumors Chan-Kwon Jung1, Ji-Han Jung1, Ahwon Lee1, Youn-Soo Lee1, Yeong-Jin Choi1, Seung-Kew Yoon2 and Kyo-Young Lee1 1Department of Hospital Pathology, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea and 2Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea Alterations in b-catenin degradation cause it to accumulate to immunohistochemically detectable levels in the nuclei of tumor cells. Although it has been shown that nuclear b-catenin immunostaining is useful for the diagnosis of some mesenchymal tumors, there is little known about b-catenin expression in endometrial stromal tumors. In this study, nuclear b-catenin immunoreactivity was evaluated in normal endometrium and endometrial mesenchymal tumors and then compared with that of CD10. The endometrial mesenchymal tumors evaluated included endometrial stromal nodules (n ¼ 2), low-grade endometrial stromal sarcomas (n ¼ 12), undifferentiated endometrial sarcomas (n ¼ 8) and uterine cellular leiomyomata (n ¼ 9). In addition, direct DNA sequencing of b-catenin exon 3 was conducted in 15 endometrial stromal tumors. Normal endometrial stromal cells showed strong cytoplasmic reactivity for CD10 but no detectable reactivity for b-catenin. Nuclear b-catenin immunoreactivity was detected in 11 low-grade endometrial stromal sarcomas (92%) and 6 undifferentiated endometrial sarcomas (75%). Ten low-grade endometrial stromal sarcomas (83%) and six undifferentiated endometrial sarcomas (75%) were positive for CD10.
    [Show full text]
  • Β-Catenin Concentrated and Prediluted Monoclonal Antibody 901-406-040819
    β-Catenin Concentrated and Prediluted Monoclonal Antibody 901-406-040819 Catalog Number: CM 406 A, C PM 406 AA VLTM 406 G20 Description: 0.1, 1.0 mL, conc. 6.0 mL, RTU 20 mL, RTU Dilution: 1:200 Ready-to-use Ready-to-use Diluent: Da Vinci Green N/A N/A Intended Use: Storage and Stability: For In Vitro Diagnostic Use Store at 2ºC to 8ºC. The product is stable to the expiration date printed β-Catenin [14] is a mouse monoclonal antibody that is intended for on the label, when stored under these conditions. Do not use after laboratory use in the qualitative identification of β-Catenin protein by expiration date. Diluted reagents should be used promptly; any immunohistochemistry (IHC) in formalin-fixed paraffin-embedded remaining reagent should be stored at 2ºC to 8ºC. (FFPE) human tissues. The clinical interpretation of any staining or its absence should be complemented by morphological studies using proper Protocol Recommendations (VALENT® Automated Slide controls and should be evaluated within the context of the patient’s Staining Platform): clinical history and other diagnostic tests by a qualified pathologist. VLTM406 is intended for use with the VALENT. Refer to the User Manual Summary and Explanation: for specific instructions for use. Protocol parameters in the Protocol Beta-catenin is involved in cell adhesion through catenin-cadherin Manager should be programmed as follows: complexes and as a transcriptional regulator in the Wnt signaling Deparaffinization: Deparaffinize for 8 minutes with Val DePar. pathway. Its deregulation is important in the genesis of a number of Pretreatment: Perform heat retrieval at 98°C for 60 minutes using Val human malignancies, particularly colorectal cancer.
    [Show full text]
  • The Ubiquitin-Proteasome Pathway Mediates Gelsolin Protein Downregulation in Pancreatic Cancer
    The Ubiquitin-Proteasome Pathway Mediates Gelsolin Protein Downregulation in Pancreatic Cancer Xiao-Guang Ni,1 Lu Zhou,2 Gui-Qi Wang,1 Shang-Mei Liu,3 Xiao-Feng Bai,4 Fang Liu,5 Maikel P Peppelenbosch,2 and Ping Zhao4 1Department of Endoscopy, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 2Department of Cell Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; 3Department of Pathology, 4Department of Abdominal Surgery, and 5State Key Laboratory of Molecular Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China A well-known observation with respect to cancer biology is that transformed cells display a disturbed cytoskeleton. The under- lying mechanisms, however, remain only partly understood. In an effort to identify possible mechanisms, we compared the pro- teome of pancreatic cancer with matched normal pancreas and observed diminished protein levels of gelsolin—an actin fila- ment severing and capping protein of crucial importance for maintaining cytoskeletal integrity—in pancreatic cancer. Additionally, pancreatic ductal adenocarcinomas displayed substantially decreased levels of gelsolin as judged by Western blot and immunohistochemical analyses of tissue micoarrays, when compared with cancerous and untransformed tissue from the same patients (P < 0.05). Importantly, no marked downregulation of gelsolin mRNA was observed (P > 0.05), suggesting that post- transcriptional mechanisms mediate low gelsolin protein levels. In apparent agreement, high activity ubiquitin-proteasome path- way in both patient samples and the BxPC-3 pancreatic cancer cell line was detected, and inhibition of the 26s proteasome sys- tem quickly restored gelsolin protein levels in the latter cell line.
    [Show full text]
  • Microtubule-Associated Protein Tau (Molecular Pathology/Neurodegenerative Disease/Neurofibriliary Tangles) M
    Proc. Nati. Acad. Sci. USA Vol. 85, pp. 4051-4055, June 1988 Medical Sciences Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau (molecular pathology/neurodegenerative disease/neurofibriliary tangles) M. GOEDERT*, C. M. WISCHIK*t, R. A. CROWTHER*, J. E. WALKER*, AND A. KLUG* *Medical Research Council Laboratory of Molecular Biology, Hills Road, Cambridge CB2 2QH, United Kingdom; and tDepartment of Psychiatry, University of Cambridge Clinical School, Hills Road, Cambridge CB2 2QQ, United Kingdom Contributed by A. Klug, March 1, 1988 ABSTRACT Screening of cDNA libraries prepared from (21). This task is made all the more difficult because there is the frontal cortex ofan zheimer disease patient and from fetal no functional or physiological assay for the protein(s) of the human brain has led to isolation of the cDNA for a core protein PHF. The only identification so far possible is the morphol- of the paired helical fiament of Alzheimer disease. The partial ogy of the PHFs at the electron microscope level, and here amino acid sequence of this core protein was used to design we would accept only experiments on isolated individual synthetic oligonucleotide probes. The cDNA encodes a protein of filaments, not on neurofibrillary tangles (in which other 352 amino acids that contains a characteristic amino acid repeat material might be occluded). One thus needs a label or marker in its carboxyl-terminal half. This protein is highly homologous for the PHF itself, which can at the same time be used to to the sequence ofthe mouse microtubule-assoiated protein tau follow the steps of the biochemical purification.
    [Show full text]
  • Neurofilaments: Neurobiological Foundations for Biomarker Applications
    Neurofilaments: neurobiological foundations for biomarker applications Arie R. Gafson1, Nicolas R. Barthelmy2*, Pascale Bomont3*, Roxana O. Carare4*, Heather D. Durham5*, Jean-Pierre Julien6,7*, Jens Kuhle8*, David Leppert8*, Ralph A. Nixon9,10,11,12*, Roy Weller4*, Henrik Zetterberg13,14,15,16*, Paul M. Matthews1,17 1 Department of Brain Sciences, Imperial College, London, UK 2 Department of Neurology, Washington University School of Medicine, St Louis, MO, USA 3 a ATIP-Avenir team, INM, INSERM , Montpellier university , Montpellier , France. 4 Clinical Neurosciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, United Kingdom 5 Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Québec, Canada 6 Department of Psychiatry and Neuroscience, Laval University, Quebec, Canada. 7 CERVO Brain Research Center, 2601 Chemin de la Canardière, Québec, QC, G1J 2G3, Canada 8 Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital Basel, University of Basel, Basel, Switzerland. 9 Center for Dementia Research, Nathan Kline Institute, Orangeburg, NY, 10962, USA. 10Departments of Psychiatry, New York University School of Medicine, New York, NY, 10016, 11 Neuroscience Institute, New York University School of Medicine, New York, NY, 10016, USA. 12Department of Cell Biology, New York University School of Medicine, New York, NY, 10016, USA 13 University College London Queen Square Institute of Neurology, London, UK 14 UK Dementia Research Institute at University College London 15 Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden 16 Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden 17 UK Dementia Research Institute at Imperial College, London * Co-authors ordered alphabetically Address for correspondence: Prof.
    [Show full text]
  • INITIAL EXPRESSION of NEUROFILAMENTS and VIMENTIN in the CENTRAL and PERIPHERAL NERVOUS SYSTEM of the MOUSE EMBRYO in Vivol
    0270-6474/84/0408-2080$02.00/O The Journal of Neuroscience Copyright 0 Society for Neuroscience Vol. 4, No. 8, pp. 2080-2094 Printed in U.S.A. August 1984 INITIAL EXPRESSION OF NEUROFILAMENTS AND VIMENTIN IN THE CENTRAL AND PERIPHERAL NERVOUS SYSTEM OF THE MOUSE EMBRYO IN VIVOl PHILIPPE COCHARD’ AND DENISE PAULIN* Institut d%mbryologie du Centre National de la Recherche Scientifique et du Collkge de France, 94130 Nogent-sur-Marne, France and *Laboratoire de Gdn&ique Cellulaire, Institut Pasteur, 75015 Paris, France Received December 9,1983; Accepted February 9, 1984 Abstract The appearance of neurofilaments (NFs) and vimentin (Vim) in the nervous system of the mouse embryo was documented using immunohistochemical techniques. The three NF protein subunits appear early and simultaneously in central and peripheral neurons at 9 to 10 days of gestation. The onset of NF expression is concomitant with axon elongation and correlates extremely well with neurofibrillar differentiation and, in the case of autonomic ganglia, with the expression of adrenergic neurotransmitter properties. In the central and peripheral nervous system, NF expression is preceded by that of Vim, and both types of intermediate filaments coexist within the same cell for a short period of time. Specific markers of neuronal and glial cell types are powerful cases, they have revealed common epitopes shared by the tools for studying the mechanisms generating cellular diversi- various classes of IF (Pruss et al., 1981; Dellagi et al., 1982; fication in the nervous system. In recent years, intermediate Gown and Vogel, 1982 and, in the NF class, by the various NF filaments (IFS), a particular class of cytoskeletal proteins, have subunits (Willard and Simon, 1981; Lee et al., 1982; Goldstein attracted much interest, largely because of their polymorphism; et al., 1983).
    [Show full text]